ML20212D751
| ML20212D751 | |
| Person / Time | |
|---|---|
| Site: | 03013426 |
| Issue date: | 05/11/1983 |
| From: | Riedlinger B NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION V) |
| To: | Zellmer P PROVIDENCE HOSP., ANCHORAGE, AK |
| Shared Package | |
| ML20197E946 | List: |
| References | |
| 14015, NUDOCS 8608120564 | |
| Download: ML20212D751 (2) | |
See also: IR 05000178/2038001
Text
!
.,
. . , .
,
en en g
<[.' f
o,
UNITED STATES
[ j ,'. 1 [%
NUCLEAR REGULATORY COMMISSION
-x
-* / c
REGION V
N
[o#[
1450 MARIA LANE SulTE 210
!
O
% >'
WALNUT CREEK, CALIFORNIA 94596
,
,
.....
License No. 50-17838-01
Al4Y 111983
!'
_
..
Docket No. 030-13426
Control No. 34015
Providence Hospital
Radiation Safety Office
Attn:
Mr. Darwin Zellmer
Medical Physicist
3200 Providence Drive
Pouch 6604 '
Anchorage, Alaska 99502
i
1
Gentlemen:
This letter is in response to your application, dated February 21, 1983 to
renew your byproduct material license for your nuclear medicine program.
Addi,tional information is needed to support your application in the following
j
areas:
1.
If Dr. Cook was an authorized user on NRC License 35-16329-02 (for the
University of Oklahoma Health Sciences Center) between the years of
1977-1979, an additional Form NRC-313M Supplement B should be completed
and signed by her preceptor to document the training and experience that
she received during that time interval.
Otherwise, in order to be considered acceptable, training and experience
must have been obtained within five years of the date of the application.
Since most of the information that Dr. Cook submitted does not meet this
criterion, she may need to obtain refresher training equivalent to that
specified in Appendix A, Sections 2.A., 2.B., and 2.C. (Appendix A is
enclosed).
Also, the preceptor statement shouJd specify the number of generator
elution and molybdenum-99 breakthrough tests that Dr. Cook has completed.
In order to authorize Dr. Cook for Group IV, we need documentation of an
additional patient treatment using colloidal P-32.
2.
Please submit a description of the thyroid probe that will be used for
patient uptake studies and for personnel bioassays.
3.
Please specify that the Radiation Safety Officer or his designee will
provide a film or TLD badge or a pocket dosimeter to each member of the
nursing staff who will care for patients being treated with therapeutic
sealed sources or radiopharmaceuticals.
8608120564 860616
REG 5 LIC30
50-17838-01
s
v..
IY014
.
.
..
, _ ,
. .
. . ,
- .
.
.
,
c
(
EAY 11 1983
, , -
Providence Hospital
-2-
,.
4.
Please specify what room will be used for the operation of the
J. L. Shepherd Model 28-5 instrument calibrator.
Also, specify the way
the area will be posted and restricted during the use of the calibrator.
..
5.
It is not clear from your procedures that the Medical Physicist will be
responsible for dispensing sealed sources.
Please clarify. Also, your
,
_
procedures state that the Medical Physicist can designate someone to act
M_
as source custodian.
Please specify those persons who could be
designated to fulfill the responsibilities of the source custodian in the
absence of the Medical Physicist.
6.
Item 14, par,e 17 of your application appears to exempt certain packages
containing licensed material from safe opening procedures.
Please note
that there are no exemptions from safe opening procedures in
l
10 CFR 20.205(d). Also, no " Radioactive Shipment Receipt Report" form
1
was submitted with your application (see page 10.8-34 of Regulatory
Guide 10.8).
Please submit the form that you plan to use for this
purpose.
7.
Item 11 of your application notes that radiation levels in unrestricted
areas are well below 2 millirem per hour. Please note that the limit of
100 millirems in any seven consecutive days as stated in 20.105(b)(2)
also applies to unrestricted areas. This limit is particularly of
interest when there is a constant radiation level in unrestricted areas
due to the storage or use of licensed materials.
In such cases, the
allowed dose rate would be approximately 0.6 millirem per hour.
8.
Please specify the location and the face velocities of the fume hoods
where liquid forms of iodine will be opened.
We will continue the review of your application upon receipt of the requested
information.
Please reply in duplicate, and reference Mail Control No. 14015.
Sincerely,
,'
s
.? (l-
&
jl
B. A. Riedlin e
Health Physicist (Licensing)
Materials Radiation Protection
Inspection and Licensing Section
Enclosure:
-
Reg. Guide 10.8, Revision 1
.
-.
--
.
y,
/%/DICi